The addition of IMiDs on daratumumab refractory multiple myeloma patients can overcome refractoriness in both agents

Maria Gavriatopoulou, Efstathios Kastritis, Ioannis Ntanasis-Stathopoulos, Despina Fotiou, Maria Roussou, Magdalini Migkou, Dimitrios Ziogas, Nikolaos Kanellias, Evangelos Terpos and Meletios Athanasios Dimopoulos

This is a PDF-only article. The first page of the PDF of this article appears below.

PDF extract preview